Diabetic Foot Ulcer Treatment
Aurealis Oy focuses on clinical research in diabetic foot ulcer care, with attention to non-healing and neuro-ischaemic wounds that require advanced local treatment options.
- Wound closure
- Non-healing ulcers
- Neuro-ischaemic foot lesions
The sponsor’s research activity is centred on topical approaches for patients with difficult-to-heal ulceration in the setting of diabetes mellitus.
Topical Microbial Therapy
The company is involved in studies of topical biologic treatment for ulcer management, including formulations designed for local application to affected tissue.
- Local wound therapy
- Microbial-based treatment
- Foam dressing applications
Research activity includes evaluation of treatment schedules intended for direct use on foot ulcer sites.
Safety and Tolerability
Aurealis Oy’s clinical programme also examines the safety and tolerability of investigational ulcer treatments in patients with chronic wounds.
- Local safety
- Systemic tolerability
- Placebo-controlled evaluation
These studies address both treatment-related effects at the wound site and broader patient-level tolerability in diabetic foot disease.
Wound Healing Outcomes
The sponsor’s research interests include clinical endpoints related to complete wound closure and the restoration of skin integrity in persistent ulceration.
- Ulcer healing
- Closure rate assessment
- Chronic wound resolution
These outcomes are central to studies of patients with foot ulcers receiving standard care alongside investigational topical therapy.
